Vasculopathy in COVID-19
R Flaumenhaft, K Enjyoji… - Blood, The Journal of the …, 2022 - ashpublications.org
COVID-19 is a primary respiratory illness that is frequently complicated by systemic
involvement of the vasculature. Vascular involvement leads to an array of complications …
involvement of the vasculature. Vascular involvement leads to an array of complications …
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke
The management of patients with stroke is often multidisciplinary, involving various
specialties and healthcare professionals. Given the common shared risk factors for stroke …
specialties and healthcare professionals. Given the common shared risk factors for stroke …
Frequency of neurological diseases after COVID-19, influenza A/B and bacterial pneumonia
Introduction COVID-19 might affect the incidence of specific neurological diseases, but it is
unknown if this differs from the risk following other infections. Here, we characterized the …
unknown if this differs from the risk following other infections. Here, we characterized the …
Reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients undergoing serial laboratory testing
Background A better understanding of reinfection after severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection has become one of the healthcare priorities in the …
coronavirus 2 (SARS-CoV-2) infection has become one of the healthcare priorities in the …
Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection: a state-of-the-art review
DH Jiang, DJ Roy, BJ Gu, LC Hassett… - Basic to Translational …, 2021 - jacc.org
The vast majority of patients (> 99%) with severe acute respiratory syndrome coronavirus 2
survive immediate infection but remain at risk for persistent and/or delayed multisystem. This …
survive immediate infection but remain at risk for persistent and/or delayed multisystem. This …
One-year adverse outcomes among US adults with post–COVID-19 condition vs those without COVID-19 in a large commercial insurance database
Importance Many individuals experience ongoing symptoms following the onset of COVID-
19, characterized as postacute sequelae of SARS-CoV-2 or post–COVID-19 condition …
19, characterized as postacute sequelae of SARS-CoV-2 or post–COVID-19 condition …
Cerebrovascular complications of COVID-19 and COVID-19 vaccination
M De Michele, J Kahan, I Berto, OG Schiavo… - Circulation …, 2022 - Am Heart Assoc
The risk of stroke and cerebrovascular disease complicating infection with SARS-CoV-2 has
been extensively reported since the onset of the pandemic. The striking efforts of many …
been extensively reported since the onset of the pandemic. The striking efforts of many …
[HTML][HTML] Neurological consequences of COVID-19 and brain related pathogenic mechanisms: a new challenge for neuroscience
F Sarubbo, K El Haji, A Vidal-Balle… - Brain, Behavior, & Immunity …, 2022 - Elsevier
Due to the infection by the SARS-CoV-2 virus (COVID-19) there were also reported
neurological symptoms, being the most frequent and best cited those that affect the …
neurological symptoms, being the most frequent and best cited those that affect the …
[HTML][HTML] Therapeutic approaches to the neurologic manifestations of COVID-19
EL Graham, IJ Koralnik, EM Liotta - Neurotherapeutics, 2022 - Elsevier
As of May 2022, there have been more than 527 million infections with severe acute
respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from …
respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from …
[HTML][HTML] The impact of COVID-19 on comorbidities: a review of recent updates for combating it
JA Malik, S Ahmed, M Shinde, MHS Almermesh… - Saudi journal of …, 2022 - Elsevier
Coronavirus disease is caused by the SARS-CoV-2 virus. The virus first appeared in Wuhan
(China) in December 2019 and has spread globally. Till now, it affected 269 million people …
(China) in December 2019 and has spread globally. Till now, it affected 269 million people …